NextCure
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$62,723,000 over the previous period. Total operating expenses were $67,637,000.

Profit Margin

NextCure, Inc. (NASDAQ:NXTC): Profit margin
2017 0 -15.46M
2018 0 -22.79M
2019 6.34M -33.73M -531.54%
2020 22.37M -33.19M -148.32%
2021 0 -69.38M
2022 0 -69.43M
2023 0 -62.72M

NXTC Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
00022.37M6.34M00
Cost of revenue
3.68M4.48M4.3M46.55K34.21K0582K
Gross profit
-3.68M-4.48M-4.3M22.33M6.31M0-582K
Operating exp.
Research and development
47.93M54.19M50.19M46.55M34.21M19.78M12.95M
Selling and marketing
0000000
Total operating expenses
67.63M75.90M70.76M63.60M43.82M23.19M15.54M
Operating income
-67.63M-75.90M-70.76M-41.22M-37.48M-23.19M-15.54M
Other income (expenses), net
4.91M1.17M1.37M4.62M3.74M397K80K
Income before tax
-62.72M-74.73M-69.38M-36.60M-33.73M-22.79M-15.46M
Income tax expense
0-5.3M0-3.41M0397K0
Net income
-62.72M-69.43M-69.38M-33.19M-33.73M-22.79M-15.46M
Earnings per share
Basic EPS
-2.25-2.5-2.51-1.21-2.15-2.27-1.54
Diluted EPS
-2.25-2.5-2.51-1.21-2.15-2.27-1.54
Data sourceData sourceData sourceData sourceData source